Molecule Information
General Information of the Molecule (ID: Mol04292)
| Name |
Glycerol-3-phosphate phosphatase (PGP)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
Aspartate-based ubiquitous Mg(2+)-dependent phosphatase ; Phosphoglycolate phosphatase
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
PGP
|
||||
| Gene ID | |||||
| Sequence |
MAAAEAGGDDARCVRLSAERAQALLADVDTLLFDCDGVLWRGETAVPGAPEALRALRARG
KRLGFITNNSSKTRAAYAEKLRRLGFGGPAGPGASLEVFGTAYCTALYLRQRLAGAPAP K AYVLGSPALAAELEAVGVASVGVGPEPLQGEGPGDWLHAPLEPDVRAVVVGFDPHFSY MK LTKALRYLQQPGCLLVGTNMDNRLPLENGRFIAGTGCLVRAVEMAAQRQADIIGKPS RFI FDCVSQEYGINPERTVMVGDRLDTDILLGATCGLKTILTLTGVSTLGDVKNNQESD CVSK KKMVPDFYVDSIADLLPALQG Click to Show/Hide
|
||||
| Function |
Glycerol-3-phosphate phosphatase hydrolyzing glycerol-3-phosphate into glycerol. Thereby, regulates the cellular levels ofglycerol-3-phosphate a metabolic intermediate of glucose, lipid andenergy metabolism. Was also shown to have a 2-phosphoglycolatephosphatase activity and a tyrosine-protein phosphatase activity.However, their physiological relevance is unclear . Invitro, also has a phosphatase activity toward ADP, ATP, GDP and GTP . {ECO:0000250|UniProtKB:Q8CHP8,ECO:0000269|PubMed:26755581}.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: B-cell non-Hodgkin lymphoma [ICD-11: 2A85.2] | [1] | |||
| Resistant Disease | B-cell non-Hodgkin lymphoma [ICD-11: 2A85.2] | |||
| Resistant Drug | Doxorubicin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | PI3K/AKT/mTOR signaling pathway | Inhibition | hsa04151 | |
| In Vitro Model | RAJI/DOX cells | Blood | Homo sapiens (Human) | N.A. |
| Mechanism Description | The expression of Pgp and the phosphorylation levels of AKT and mTOR in RAJI/DOX cell line were both higher than those in RAJI cell line. NVP-BEZ235 downregulated the phosphorylation levels of AKT and mTOR in RAJI/DOX cell line. NVP-BEZ235 inhibited the proliferation of RAJI/DOX cell line, and the effect was obvious when it was cooperated with doxorubicin. The constitutive activation of PI3K/AKT/mTOR pathway of RAJI/DOX cell line was more serious than RAJI cell line. NVP-BEZ235 reversed doxorubicin resistance of RAJI/DOX cell line by inhibiting the PI3K/AKT/mTOR signal pathway. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
